Mary Kay Koenig, MD
The University of Texas Health Science Center, Houston
3
3
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Hope Northrup, MD
The University of Texas Health Science Center, Houston
Shared therapeutic areas:
Worked with same sponsors:
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Staci M Peron, Ph.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Ana-Maria Vranceanu, PhD
Massachusetts General Hospital
Shared therapeutic areas:
Kim E. Nichols, MD
St. Jude Children's Research Hospital
Shared therapeutic areas:
Douglas R Stewart, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
AeRang Kim, MD, PhD
Children's National Research Institute
Shared therapeutic areas:
Didier BESSIS, PhD
University Hospitals of Montpellier
Shared therapeutic areas:
Roger J. Packer, MD
Children's National Research Institute
Shared therapeutic areas:
Vanessa Merker, PhD
Massachusetts General Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
The International Registry for Leigh Syndrome
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T
All 3 trials loaded